TCM
IRWD icon

Teza Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Teza Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,240
Closed -$38.6K – 410
2025
Q1 		$38.6K Buy
26,240
+1,807
+7% +$4.3K 0.02% 402
2024
Q4 		$108K Sell
24,433
-2,788
-10% -$11.3K 0.02% 454
2024
Q3 		$112K Sell
27,221
-8,859
-25% -$47.6K 0.01% 563
2024
Q2 		$235K Buy
36,080
+14,347
+66% +$101K 0.03% 503
2024
Q1 		$189K Buy
+21,733
New +$264K 0.03% 523
2023
Q3 		– Sell
-70,974
Closed -$755K – 681
2023
Q2 		$755K Buy
70,974
+51,942
+273% +$558K 0.12% 227
2023
Q1 		$200K Buy
+19,032
New +$213K 0.04% 468

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Teza Capital Management's IRWD Position: Q2 2025 in Review

Teza Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 26,240 shares — an estimated $38.6K sold.

Teza Capital Management first reported a position in IRWD in Q1 2023 and held it in 7 quarters. The position peaked at $755K in Q2 2023. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • Teza Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Teza Capital Management sold 26,240 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $38.6K.
  • Teza Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2023 and held it in 7 quarters.
  • Teza Capital Management's Ironwood Pharmaceuticals position peaked at $755K in Q2 2023.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Teza Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.